Genes in panel
STRs in panel
Prev Next

Early onset or syndromic epilepsy

Gene: SLC5A6

Red List (low evidence)

SLC5A6 (solute carrier family 5 member 6)
EnsemblGeneIds (GRCh38): ENSG00000138074
EnsemblGeneIds (GRCh37): ENSG00000138074
OMIM: 604024, Gene2Phenotype
SLC5A6 is in 5 panels

3 reviews

Helen Lord (Oxford Medical Genetics Laboratories)

Red List (low evidence)

PMID 35013551 Holling et al, 2022 - reporting 5 individuals from 3 families with motor neuropathies. Hom variant c.1285A>G p.(Ser429Gly) in 3 aff siblings and a simplex patient; and a third family where proband had a mat inherited c.280C>T p.(Arg94*) and a pat inherited c.485A>G p.(Tyr162Cys). in silico tools suggest missense variants affect function. No mention of epilepsy in any of these individuals.

PMID 38036278 Hsieh et al 2023 - Family with compound het SLC5A6 missense variants reported. No mention of epilepsy in affected individuals.

PMID 38012394 Utsuno et al 2024 - 3 sibs from a Japanese family with periventricular brain cysts and motor developmental delay - all compund het for SLC5A6 missense variants - no mention of epilepsy/seizure in any of these sibs.

PMID 37391029 Montomoli et al 2023 - 3 members of the same family - Patient 2 had a generalised tonic-clonic seizre and EEG showed sharp waves in left centro-temporal region. No mention of seizures at follow up at 24 years of age, and no mention prior to this seizure but lots of other clinical features. All affecteds had a hom fs SLC5A6 variant, parents het. Table summarising cases showed epilepsy in 2/13 case - patient 2 in this paper and the Byrne et al paper.

PMID 31754459 Byrne et al - see review 31/01/2021.

No new evidence to support a stronger link with SLC5A6 and an epilepsy phenotype.
Created: 7 Feb 2024, 4:22 p.m. | Last Modified: 7 Feb 2024, 4:22 p.m.
Panel Version: 4.163
Byrne et al, 2019 - sibling pair displaying an early infantile-onset, progressive neurodegenerative phenotype with symptoms of dev delay and epileptic encephalopathy, developing from 12-14 months of age - only seen in one of the sibs. Pathogenicity of the identified variants was demonstrated by impaired biotin uptake of mutant SMTV. Idenitification of this disorder guided targeted therepeuitc intervention, resulting clinically in improvement of the patients neurocognitive and neuromotor function. Subramanian et al, 2017 - 2 variants identified in a child by WGS - no mention of epilepsy seen in this individual. Not enough evidence to suggest this gene is associated with epilepsy.
Created: 31 Jan 2021, 9 p.m. | Last Modified: 31 Jan 2021, 9 p.m.
Panel Version: 2.281

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Publications

Sarah Leigh (Genomics England Curator)

Red List (low evidence)

There is insufficient evidence of epilepsy associated with SLC5A6 variants (PMID: 35013551; 38036278; 38012394; 37391029; 31754459) for this gene to be rated as Amber on the Early onset or syndromic epilepsy, therefore it have been demoted to Red.
Created: 29 Feb 2024, 2:16 p.m. | Last Modified: 29 Feb 2024, 2:16 p.m.
Panel Version: 4.173
The to_be_confirmed_NHSE tag has been added, as further NHSE review is required.
Created: 15 Mar 2022, 3:32 p.m. | Last Modified: 15 Mar 2022, 3:32 p.m.
Panel Version: 2.498
For review tag has been added, to allow for GMS discussion in relation to the metabolic role of this gene. There are insufficient cases with seizures to be green on the Genetic epilepsy syndromes panel.
Created: 26 Oct 2020, 3:22 p.m. | Last Modified: 1 Feb 2021, 3:23 p.m.
Panel Version: 2.285
Watchlist tag was added to take account of the potential therapeutic options of this cause of seizures.
Created: 8 Jul 2020, 9:40 a.m. | Last Modified: 8 Jul 2020, 9:40 a.m.
Panel Version: 2.113
Comment on list classification: Not associated with phenotype in OMIM and as possible Gen2Phen gene for SLC5A6-related Neurodevelopmental Disorder. At least 4 variants published in two unrelated famililies (3 cases total) with SLC5A6-related Neurodevelopmental Disorder, together with supportive functional studies. One of the cases had mixed semiology seizures including focal dyscognitive, absence, tonic spasms and generalised convulsive seizures with electrographic features of encephalopathy with generalised and independent multifocal spike-wave discharges (PMID 31754459).
Created: 2 Jun 2020, 5:31 p.m. | Last Modified: 2 Jun 2020, 5:31 p.m.
Panel Version: 2.85

Zornitza Stark (Australian Genomics)

Green List (high evidence)

Two unrelated families reported, functional data and some evidence of response to treatment.
Sources: Expert list
Created: 25 Jan 2020, 6:55 a.m.

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Developmental delay; epilepsy; neurodegeneration

Publications

Variants in this GENE are reported as part of current diagnostic practice

Details

Mode of Inheritance
BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Red
Phenotypes
  • Neurodegeneration, infantile-onset, biotin-responsive, OMIM:618973
OMIM
604024
Clinvar variants
Variants in SLC5A6
Penetrance
None
Publications
Panels with this gene

History Filter Activity

29 Feb 2024, Gel status: 1

Set publications

Sarah Leigh (Genomics England Curator)

Publications for gene: SLC5A6 were set to 27904971; 31392107; 31754459; 23104561; 29669219

29 Feb 2024, Gel status: 1

Entity classified by Genomics England curator

Sarah Leigh (Genomics England Curator)

Gene: slc5a6 has been classified as Red List (Low Evidence).

29 Feb 2024, Gel status: 2

Removed Tag, Removed Tag, Removed Tag

Sarah Leigh (Genomics England Curator)

Tag watchlist was removed from gene: SLC5A6. Tag for-review was removed from gene: SLC5A6. Tag to_be_confirmed_NHSE was removed from gene: SLC5A6.

6 Apr 2022, Gel status: 2

Set Phenotypes

Arina Puzriakova (Genomics England Curator)

Phenotypes for gene: SLC5A6 were changed from SLC5A6-related Neurodevelopmental Disorder to Neurodegeneration, infantile-onset, biotin-responsive, OMIM:618973

3 Mar 2022, Gel status: 2

Added Tag

Sarah Leigh (Genomics England Curator)

Tag to_be_confirmed_NHSE tag was added to gene: SLC5A6.

26 Oct 2020, Gel status: 2

Added Tag

Sarah Leigh (Genomics England Curator)

Tag for-review tag was added to gene: SLC5A6.

8 Jul 2020, Gel status: 2

Added Tag

Sarah Leigh (Genomics England Curator)

Tag watchlist tag was added to gene: SLC5A6.

2 Jun 2020, Gel status: 2

Set publications

Sarah Leigh (Genomics England Curator)

Publications for gene: SLC5A6 were set to 31754459; 27904971

2 Jun 2020, Gel status: 2

Set Phenotypes

Sarah Leigh (Genomics England Curator)

Phenotypes for gene: SLC5A6 were changed from Developmental delay; epilepsy; neurodegeneration to SLC5A6-related Neurodevelopmental Disorder

2 Jun 2020, Gel status: 2

Entity classified by Genomics England curator

Sarah Leigh (Genomics England Curator)

Gene: slc5a6 has been classified as Amber List (Moderate Evidence).

25 Jan 2020, Gel status: 0

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes

Zornitza Stark (Australian Genomics)

gene: SLC5A6 was added gene: SLC5A6 was added to Genetic epilepsy syndromes. Sources: Expert list Mode of inheritance for gene: SLC5A6 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: SLC5A6 were set to 31754459; 27904971 Phenotypes for gene: SLC5A6 were set to Developmental delay; epilepsy; neurodegeneration Review for gene: SLC5A6 was set to GREEN gene: SLC5A6 was marked as current diagnostic